Revolutionary DNA-Reading Technology Enhances Rare Disease Research

A cutting-edge DNA mapping technology has made significant strides in uncovering new genetic insights that could revolutionize the understanding and diagnosis of rare pediatric diseases. Presented at the Pediatric Academic Societies (PAS) 2025 Meeting in Honolulu, the research showcases how this innovative approach can identify far more genomic imprinting than previously documented—up to ten times more. Genomic imprinting is a process where only one parent’s gene is active in the child's DNA, playing a critical role in the manifestation of certain rare conditions.

The technology, known as HiFi long-read sequencing, provides researchers with the ability to detect DNA pattern variations, especially those linked to paternal or maternal origins. This capability could pave the way for more accurate diagnoses and a better understanding of human development and disease.

In the study, scientists analyzed over 200 genetic samples from cells of nearly 70 placentas, each only six to eight weeks old, obtained from Children’s Mercy Kansas City. The findings suggest that this technology can reveal previously hidden genetic information, opening new avenues for research into rare genetic disorders.

Dr. Elin Grundberg, from the Genomic Medicine Center at Children’s Mercy Kansas City, emphasized the potential of this technology: "Genomic research is experiencing a revolution, and new tools like HiFi long-read sequencing are fundamental in revealing intricate details of human genetics that could lead to novel treatments and diagnostic methods for rare diseases."

For further details, the study titled "Mapping parent of origin methylation by long-read sequencing reveals novel imprinting and insight into pediatric disease" provides comprehensive insights into this groundbreaking work.